An Observational Cross-Sectional Study of Gender and Disability as Determinants of Person-Centered Medicine in Botulinum Neurotoxin Treatment of Upper Motoneuron Syndrome
Authors: Del Prete CM, Viva MG, De Trane S, Brindisino F, Barassi G, Specchia A, Di Iorio A, Pellegrino R.. Toxins (Basel). 2022 Mar 30;14(4):246. doi: 10.3390/toxins14040246. PMID: 35448855; PMCID: PMC9024520.
Cervical Spine Manipulations: Role of Diagnostic Procedures, Effectiveness, and Safety from a Rehabilitation and Forensic Medicine Perspective: A Systematic Review
Authors: Bernetti A, La Russa R, de Sire A, Agostini F, De Simone S, Farì G, Lacasella GV, Santilli G, De Trane S, Karaboue M, Ruiu P, Mangone M, Leigheb M, Santilli V, Fiore P.. Diagnostics (Basel). 2022 Apr 23;12(5):1056. doi: 10.3390/diagnostics12051056. PMID: 35626212; PMCID: PMC9139983.
Therapeutic Exercise and Conservative Injection Treatment for Early Knee Osteoarthritis in Athletes: A Scoping Review
Authors: Tognolo L, Maccarone MC, De Trane S, Scanu A, Masiero S, Fiore P. Medicina (Kaunas). 2022 Jan 3;58(1):69. doi: 10.3390/medicina58010069. PMID: 35056377; PMCID: PMC8778069.
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
Authors: Allen-Philbey K, De Trane S, Mao Z, Álvarez-González C, Mathews J, MacDougall A, Stennett A, Zhou X, Yildiz O, Adams A, Bianchi L, Blain C, Chapman C, Chung K, Constantinescu CS, Dalton C, Farrell RA, Fisniku L, Ford H, Gran B, Hobart J, Khaleeli Z, Mattoscio M, Pavitt S, Pearson O, Peruzzotti-Jametti L, Scalfari A, Sharrack B, Silber E, Tallantyre EC, Webb S, Turner BP, Marta M, Gnanapavan S, Juliusson G, Giovannoni G, Baker D, Schmierer K. Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Ther Adv Neurol Disord. 2021 Nov 25;14:17562864211057661. doi: 10.1177/17562864211057661. PMID: 35173808; PMCID: PMC8842147.
Intensive Neurofeedback-based Training to Improve Impaired Attention and Executive Functions Secondary to Resection of Tuberculum Sellae Meningioma: A Case Study
Authors: Gianvito Lagravinese, MsC, Rodolfo Sardone, MPh, Stefania De Trane, MD, Fabiana Montenegro, BSc, Ernesto Losavio, MD, Pietro Fiore, MD, Petronilla Battista, PhD. Neuroregulation. 2021.09.30
DOI: https://doi.org/10.15540/nr.8.3.149.
Evidence for a Window of Enhanced Plasticity in the Human Motor Cortex Following Ischemic Stroke
Authors: Brenton Hordacre, Duncan Austin, Katlyn E Brown, Lynton Graetz, Isabel Pareés, Stefania De Trane, Ann-Maree Vallence, Simon Koblar, Timothy Kleinig, Michelle N McDonnell, Richard Greenwood, Michael C Ridding, John C Rothwell
Neurorehabil Neural Repair. 2021 Apr;35(4):307-320. doi: 10.1177/1545968321992330. Epub 2021 Feb 12.
Severe skin reactions associated with cladribine in people with multiple sclerosis
Authors: Mateo-Casas M, Reyes S, O'Toole EA, De Trane S, Yildiz O, Allen-Philbey K, Mathews J, Baker D, Giovannoni G, Schmierer K.
Mult Scler Relat Disord. 2020 Aug;43:102140. doi: 10.1016/j.msard.2020.102140. Epub 2020 Apr 28. PMID: 32454296
Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?
Authors: Mateo-Casas M, Reyes S, De Trane S, Edwards F, Espasandin M, Anjorin G, Baker D, Schmierer K, Giovannoni G.
eNeurologicalSci. 2020 Oct 9;21:100279. doi: 10.1016/j.ensci.2020.100279. eCollection 2020 Dec. PMID: 33163633
Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.
Authors: Mao Z, Álvarez-González C, Allen-Philbey K, De Trane S, Yildiz O, Campion T, Adams A, Turner BP, Marta M, Gnanapavan S, Espasandin M, Mathews J, Giovannoni G, Baker D, Schmierer K.
Mult Scler Relat Disord. 2019 Jan;27:247-253. doi: 10.1016/j.msard.2018.11.001. Epub 2018 Nov 2. PMID: 30419510
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
Authors: Mao Z, Álvarez-Gonzalez C, De Trane S, Yildiz O, Albor C, Doctor G, Soon D, Pepper G, Turner BP, Marta M, Mathews J, Giovannoni G, Baker D, Schmierer K.
Mult Scler J Exp Transl Clin. 2018 Jun 26;4(2):2055217318783767. doi: 10.1177/2055217318783767. eCollection 2018 Apr-Jun. PMID: 30090639
